About: Forest plots and the interpretation of subgroups

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Forest plots and the interpretation of subgroups Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 2005

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2005 (fr) наукова стаття, опублікована у квітні 2005 (uk) artículu científicu espublizáu n'abril de 2005 (ast) scientific article published on 01 April 2005 (en)
publication date	wds:Q81637902-44548E39-71DE-4AAA-97DB-792891D2AFFE
publication date	2005-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q81637902-B43D8FA8-C280-41BF-890F-F82CF59C3939
language of work or name	English
cites work	wds:Q81637902-0E3B6DC6-E560-420F-91C6-A0E223DE262A wds:Q81637902-46E265E2-C83F-4343-A0B6-CE67D446B8A3 wds:Q81637902-6EEE4478-C536-4679-B28C-3274C628B21E wds:Q81637902-C27D0012-B90F-4C4A-8A57-4DA709A3C458
cites work	Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
author name string	wds:Q81637902-7AD9EF10-84F2-4BF6-B26E-A153257AE9BA
author name string	Jack Cuzick
rdfs:label	Forest plots and the interpretation of subgroups (en) Forest plots and the interpretation of subgroups (nl)
skos:prefLabel	Forest plots and the interpretation of subgroups (en) Forest plots and the interpretation of subgroups (nl)
name	Forest plots and the interpretation of subgroups (en) Forest plots and the interpretation of subgroups (nl)
title	wds:Q81637902-65CB9F59-BDCF-4C04-8FCB-3102BBD4209B
title	Forest plots and the interpretation of subgroups (en)
page(s)	wds:Q81637902-E1F9BFE1-0ADA-43C5-A18D-8423CEC88635
page(s)	1308
instance of	wds:Q81637902-A4483BD7-9E70-49F9-9C4B-12E4C4BC2A35
instance of	scholarly article
PubMed ID	wds:Q81637902-AF28CF34-7F4D-4243-A89F-E8FDB92E05EF
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15823379
PubMed ID	15823379
published in	wds:Q81637902-ABABEC23-AD79-410D-B527-CFA4AFE1E322
published in	The Lancet
issue	wds:Q81637902-9F7BAF7F-92C3-42A6-8DAF-E3105FB6CD9B
volume	wds:Q81637902-5310C219-5B99-4BEC-AEFA-7C836D4E6ECD
issue	9467
volume	365
DOI	wds:Q81637902-68B1C656-BE0F-4C2A-90A4-612A623017B0
DOI	http://dx.doi.org/10.1016/S0140-6736(05)61026-4
DOI	10.1016/S0140-6736(05)61026-4
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81637902
is cites work of	Figures in clinical trial reports: current practice & scope for improvement Interpretation of the evidence for the efficacy and safety of statin therapy Evaluation of treatment-effect heterogeneity using biomarkers measured on a continuous scale: subpopulation treatment effect pattern plot. How to interpret figures in reports of clinical trials Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial. The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis In vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a meta-analysis Differential diagnosis between malignant and benign breast lesions using single-voxel proton MRS: a meta-analysis. Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93. Rationale and design of the multicenter randomized trial investigating the effects of levosimendan pretreatment in patients with low ejection fraction (≤40 %) undergoing CABG with cardiopulmonary bypass (LICORN study). Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial. Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study Serum C3/C4 ratio is a novel predictor of renal prognosis in patients with IgA nephropathy: a retrospective study Using clinical trial data to tailor adjuvant treatments for individual patients Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial Do client attributes moderate the effectiveness of a group cognitive behavioral therapy for depression in addiction treatment? 1H-MRS evaluation of breast lesions by using total choline signal-to-noise ratio as an indicator of malignancy: a meta-analysis. Differential diagnosis between hepatic metastases and benign focal lesions using DWI with parallel acquisition technique: a meta-analysis. Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors. Cancer Prevention: Obstacles, Challenges and the Road Ahead. Radiotherapy for breast cancer, the TARGIT-A trial Making sense of meta-analysis in medical education research Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial Patient characteristics associated with greater blood pressure control in a randomized trial of home blood pressure telemonitoring and pharmacist management. Effect of Hypokalemia on Functional Outcome at 3 Months Post-Stroke Among First-Ever Acute Ischemic Stroke Patients The Use of Meta-Analysis and Forest Plots to Examine and Display Data in Oncology Research Assessing risk factors with information beyond P value thresholds: Statistical significance does not equal clinical importance Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
is cites work of	wds:Q39122457-2F212C46-0C8B-4D2A-94D7-8BA903C20CC8 wds:Q37170626-98F23EAD-2EC5-4CD0-9105-B0725D17798C wds:Q88930619-C084FBD6-F456-4EB3-BDCA-1552FDCEF462 wds:Q46094335-EC472AED-82A5-4A00-9EC7-4A8450361F12 wds:Q64226549-F1FB94A7-3B36-4A7F-9B6A-52CFCA0C4F1E wds:Q53171108-F627440D-A57F-4837-8C4A-AEE431B8D4BA wds:Q53138050-3464FFE2-CA2C-48A7-848D-E3A53BF875A0 wds:Q38348770-329E2567-DB3D-4113-AD85-1108E419E3E1 wds:Q36659104-39EA8BB3-1F77-419B-B4F9-53F61B3E8377 wds:Q38372545-6D5D63D3-EEFF-42D1-AF08-C51163C41634 wds:Q37059919-9B4BED91-42E0-4441-B8F3-9C91688BC5FF wds:Q37154191-F93FAFB4-4E6B-42D3-BFFF-0136A42463CF wds:Q35899984-3A053E81-60FC-4DE5-A9F5-0914FD6AE848 wds:Q33811116-1D9601D3-876A-4D8B-BE9C-CC3BC76E0778 wds:Q30245459-949D2326-DA7B-4C5B-A294-CDA2328C6B3B wds:Q34334964-475AD9D6-D39E-4D3C-A698-F4472671CD62 wds:Q35460114-43D29B12-9626-471D-8FBB-E11E79C1B8F8 wds:Q87892508-B0EB4353-CE1B-4059-9E34-51557C1A6879 wds:Q31122593-E7DD0FA4-20AC-4D60-98B4-AFB6491F2283 wds:Q26795501-0D30C0F9-2784-44BF-8C83-1E397B05B357 wds:Q36419340-060021F0-E769-4AF3-AF74-1A561B982963 wds:Q42742751-5022A8C3-D895-41DC-A514-F5304C2A4F50 wds:Q37002946-B9ACEC75-5CD6-4700-AF3D-0F22C909516B wds:Q37230550-86BC3D75-A578-48F5-8ADA-80C18792FE53

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software